21.02.2017 • NewsDede WillamsoxochimieIneos

Arkema Selling Oxochimie Stake to Ineos

(c) Arkema
(c) Arkema

Arkema has announced plans to sell its half of oxo alcohols manufacturer Oxochimie, along with associated businesses, to joint venture partner Ineos. The company based at Lavera, France, is one of Europe’s largest producers of the petrochemical raw materials n-butanol, 2-ethylhexanol, isobutanol, n-butyraldehyde and isobutyraldehyde.

Terms of the deal are due to be finalized shortly, following talks with the company’s works councils and regulatory approvals. Arkema said the sale of its Oxochimie stake is part of a plan to divest assets with €700 million in annual sales.

The French specialty chemicals producers uses part of the Lavera output as a feedstock for its European acrylic esters production. The remaining volumes are sold on the free market, in particular as plasticisers for PVC, and generate annual sales of around €40m. As sole owner of Oxochimie, Ineos will continue to supply Arkema’s acrylic esters production.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read